These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36310229)

  • 21. Seeding and cross-seeding fibrillation of N-terminal prion protein peptides PrP(120-144).
    Wang Y; Hall CK
    Protein Sci; 2018 Jul; 27(7):1304-1313. PubMed ID: 29637634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wild-type hen egg white lysozyme aggregation in vitro can form self-seeding amyloid conformational variants.
    Sivalingam V; Prasanna NL; Sharma N; Prasad A; Patel BK
    Biophys Chem; 2016 Dec; 219():28-37. PubMed ID: 27710900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
    Jones EM; Surewicz WK
    Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Observation of Competing Prion Protein Fibril Populations with Distinct Structures and Kinetics.
    Sun Y; Jack K; Ercolani T; Sangar D; Hosszu L; Collinge J; Bieschke J
    ACS Nano; 2023 Apr; 17(7):6575-6588. PubMed ID: 36802500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genesis of tramsmissible protein states via deformed templating.
    Makarava N; Baskakov IV
    Prion; 2012 Jul; 6(3):252-5. PubMed ID: 22561163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid fibril proteins.
    Xing Y; Higuchi K
    Mech Ageing Dev; 2002 Nov; 123(12):1625-36. PubMed ID: 12470900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils.
    Yan J; Fu X; Ge F; Zhang B; Yao J; Zhang H; Qian J; Tomozawa H; Naiki H; Sawashita J; Mori M; Higuchi K
    Am J Pathol; 2007 Jul; 171(1):172-80. PubMed ID: 17591964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The allure and pitfalls of the prion-like aggregation in neurodegeneration.
    Ezzat K; Espay AJ
    Handb Clin Neurol; 2023; 193():17-22. PubMed ID: 36803809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic prions with novel strain-specified properties.
    Moda F; Le TN; Aulić S; Bistaffa E; Campagnani I; Virgilio T; Indaco A; Palamara L; Andréoletti O; Tagliavini F; Legname G
    PLoS Pathog; 2015 Dec; 11(12):e1005354. PubMed ID: 26720726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region.
    Cobb NJ; Apostol MI; Chen S; Smirnovas V; Surewicz WK
    J Biol Chem; 2014 Jan; 289(5):2643-50. PubMed ID: 24338015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-aggregation and secondary nucleation in the life cycle of human prolactin/galanin functional amyloids.
    Chatterjee D; Jacob RS; Ray S; Navalkar A; Singh N; Sengupta S; Gadhe L; Kadu P; Datta D; Paul A; Arunima S; Mehra S; Pindi C; Kumar S; Singru P; Senapati S; Maji SK
    Elife; 2022 Mar; 11():. PubMed ID: 35257659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly promiscuous nature of prion polymerization.
    Makarava N; Lee CI; Ostapchenko VG; Baskakov IV
    J Biol Chem; 2007 Dec; 282(50):36704-13. PubMed ID: 17940285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The physical dimensions of amyloid aggregates control their infective potential as prion particles.
    Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF
    Elife; 2017 Sep; 6():. PubMed ID: 28880146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying the sequence-dependent species barrier between hamster and mouse prions.
    Lee LY; Chen RP
    J Am Chem Soc; 2007 Feb; 129(6):1644-52. PubMed ID: 17243682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease-associated prion protein is not detectable in human systemic amyloid deposits.
    Tennent GA; Head MW; Bishop M; Hawkins PN; Will RG; Knight R; Peden AH; McCardle LM; Ironside JW; Pepys MB
    J Pathol; 2007 Dec; 213(4):376-83. PubMed ID: 17955450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126.
    Chatterjee B; Lee CY; Lin C; Chen EH; Huang CL; Yang CC; Chen RP
    PLoS One; 2013; 8(7):e67967. PubMed ID: 23844138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.